Download PDF
Clin Colon Rectal Surg 2013; 26(02): 075-079
DOI: 10.1055/s-0033-1348044
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Preoperative Optimization of Crohn Disease

Amit Sharma
1   Division of Colon and Rectal Surgery, University of Medicine and Dentistry, Robert Wood Johnson Medical School, Edison, New Jersey
,
Bertram T. Chinn
1   Division of Colon and Rectal Surgery, University of Medicine and Dentistry, Robert Wood Johnson Medical School, Edison, New Jersey
› Author Affiliations
Further Information

Publication History

Publication Date:
27 June 2013 (online)

Also available at
    Permissions and Reprints

Abstract

Crohn disease is a chronic disease that is treated with aminosalicylates, antibiotics, and immunosuppressant agents. Most patients ultimately require surgical intervention and many will require additional surgery for recurrent disease. Consequently, surgery is generally performed only when medical management fails; however, these patients are often malnourished and immunosuppressed. Preoperative optimization is necessary to minimize morbidity, including intra-abdominal septic complications and anastomotic leaks. In this article, the authors review some considerations to improve the surgical outcome in Crohn disease.

Keywords

Crohn disease - immunomodulators - biologic therapy - steroids - nutrition
 

  • References

  • 1 Loftus Jr EV, Schoenfeld P, Sandborn WJ. The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review. Aliment Pharmacol Ther 2002; 16 (1) 51-60
    CrossrefPubMedGoogle Scholar
  • 2 Wagner IJ, Rombeau JL. Nutritional support of surgical patients with inflammatory bowel disease. Surg Clin North Am 2011; 91 (4) 787-803 , viii
    CrossrefPubMedGoogle Scholar
  • 3 Tay GS, Binion DG, Eastwood D, Otterson MF. Multivariate analysis suggests improved perioperative outcome in Crohn's disease patients receiving immunomodulator therapy after segmental resection and/or strictureplasty. Surgery 2003; 134 (4) 565-572 , discussion 572–573
    CrossrefPubMedGoogle Scholar
  • 4 Smedh K, Andersson M, Johansson H, Hagberg T. Preoperative management is more important than choice of sutured or stapled anastomosis in Crohn's disease. Eur J Surg 2002; 168 (3) 154-157
    CrossrefPubMedGoogle Scholar
  • 5 Alves A, Panis Y, Bouhnik Y, Pocard M, Vicaut E, Valleur P. Risk factors for intra-abdominal septic complications after a first ileocecal resection for Crohn's disease: a multivariate analysis in 161 consecutive patients. Dis Colon Rectum 2007; 50 (3) 331-336
    CrossrefPubMedGoogle Scholar
  • 6 Yamamoto T, Allan RN, Keighley MRB. Risk factors for intra-abdominal sepsis after surgery in Crohn's disease. Dis Colon Rectum 2000; 43 (8) 1141-1145
    CrossrefPubMedGoogle Scholar
  • 7 White JV, Guenter P, Jensen G, Malone A, Schofield M. Academy Malnutrition Work Group, A.S.P.E.N. Malnutrition Task Force, A.S.P.E.N. Board of Directors. Consensus statement: Academy of Nutrition and Dietetics and American Society for Parenteral and Enteral Nutrition: characteristics recommended for the identification and documentation of adult malnutrition (undernutrition). JPEN J Parenter Enteral Nutr 2012; 36 (3) 275-283
    CrossrefPubMedGoogle Scholar
  • 8 Meijers JM, van Bokhorst-de van der Schueren MA, Schols JM, Soeters PB, Halfens RJ. Defining malnutrition: mission or mission impossible?. Nutrition 2010; 26 (4) 432-440
    CrossrefPubMedGoogle Scholar
  • 9 Razack R, Seidner DL. Nutrition in inflammatory bowel disease. Curr Opin Gastroenterol 2007; 23 (4) 400-405
    CrossrefPubMedGoogle Scholar
  • 10 Passos RA, Santana GO, Andrade A , et al. Response to cachexia in Crohn's disease following treatment with anti-TNF; a case report. Rev Bras Nutr Clin 2006; 21: 333-336
    PubMedGoogle Scholar
  • 11 Badia-Tahull MB, Llop-Talaveron J, Fort-Casamartina E , et al. Preoperative albumin as a predictor of outcome in gastrointestinal surgery. e-SPEN, Eur e-J Clin Nutr Metab 2009; 4 (5) e248-e251
    PubMedGoogle Scholar
  • 12 Saha AK, Tapping CR, Foley GT , et al. Morbidity and mortality after closure of loop ileostomy. Colorectal Dis 2009; 11 (8) 866-871
    CrossrefPubMedGoogle Scholar
  • 13 Mäkelä JT, Kiviniemi H, Laitinen S. Risk factors for anastomotic leakage after left-sided colorectal resection with rectal anastomosis. Dis Colon Rectum 2003; 46 (5) 653-660
    CrossrefPubMedGoogle Scholar
  • 14 Suding P, Jensen E, Abramson MA, Itani K, Wilson SE. Definitive risk factors for anastomotic leaks in elective open colorectal resection. Arch Surg 2008; 143 (9) 907-911 , discussion 911–912
    CrossrefPubMedGoogle Scholar
  • 15 Telem DA, Chin EH, Nguyen SQ, Divino CM. Risk factors for anastomotic leak following colorectal surgery: a case-control study. Arch Surg 2010; 145 (4) 371-376 , discussion 376
    CrossrefPubMedGoogle Scholar
  • 16 Jacobson S. Early postoperative complications in patients with Crohn's disease given and not given preoperative total parenteral nutrition. Scand J Gastroenterol 2012; 47 (2) 170-177
    CrossrefPubMedGoogle Scholar
  • 17 Allardyce DB. Preoperative parenteral feeding in Crohn's disease: preoperatively, to induce remission, and at home. Am Surg 1978; 44 (8) 510-516
    PubMedGoogle Scholar
  • 18 Lashner BA, Evans AA, Hanauer SB. Preoperative total parenteral nutrition for bowel resection in Crohn's disease. Dig Dis Sci 1989; 34 (5) 741-746
    CrossrefPubMedGoogle Scholar
  • 19 Hartman C, Eliakim R, Shamir R. Nutritional status and nutritional therapy in inflammatory bowel diseases. World J Gastroenterol 2009; 15 (21) 2570-2578
    CrossrefPubMedGoogle Scholar
  • 20 O'Moráin C, Segal AW, Levi AJ. Elemental diet as primary treatment of acute Crohn's disease: a controlled trial. Br Med J (Clin Res Ed) 1984; 288 (6434) 1859-1862
    CrossrefPubMedGoogle Scholar
  • 21 Saverymuttu S, Hodgson HJ, Chadwick VS. Controlled trial comparing prednisolone with an elemental diet plus non-absorbable antibiotics in active Crohn's disease. Gut 1985; 26 (10) 994-998
    CrossrefPubMedGoogle Scholar
  • 22 Okada M, Yao T, Yamamoto T , et al. Controlled trial comparing an elemental diet with prednisolone in the treatment of active Crohn's disease. Hepatogastroenterology 1990; 37 (1) 72-80
    PubMedGoogle Scholar
  • 23 Zoli G, Carè M, Parazza M , et al. A randomized controlled study comparing elemental diet and steroid treatment in Crohn's disease. Aliment Pharmacol Ther 1997; 11 (4) 735-740
    CrossrefPubMedGoogle Scholar
  • 24 Yamamoto T, Nakahigashi M, Umegae S, Kitagawa T, Matsumoto K. Impact of long-term enteral nutrition on clinical and endoscopic recurrence after resection for Crohn's disease: a prospective, non-randomized, parallel, controlled study. Aliment Pharmacol Ther 2007; 25 (1) 67-72
    PubMedGoogle Scholar
  • 25 Lee G, Buchman AL. DNA-driven nutritional therapy of inflammatory bowel disease. Nutrition 2009; 25 (9) 885-891
    CrossrefPubMedGoogle Scholar
  • 26 Han PD, Burke A, Baldassano RN, Rombeau JL, Lichtenstein GR. Nutrition and inflammatory bowel disease. Gastroenterol Clin North Am 1999; 28 (2) 423-443 , ix
    CrossrefPubMedGoogle Scholar
  • 27 Trebble TM, Arden NK, Wootton SA , et al. Fish oil and antioxidants alter the composition and function of circulating mononuclear cells in Crohn disease. Am J Clin Nutr 2004; 80 (5) 1137-1144
    PubMedGoogle Scholar
  • 28 Post S, Betzler M, von Ditfurth B, Schürmann G, Küppers P, Herfarth C. Risks of intestinal anastomoses in Crohn's disease. Ann Surg 1991; 213 (1) 37-42
    CrossrefPubMedGoogle Scholar
  • 29 Xie Y, Zhu W, Li N, Li J. The outcome of initial percutaneous drainage versus surgical drainage for intra-abdominal abscesses in Crohn's disease. Int J Colorectal Dis 2012; 27 (2) 199-206
    CrossrefPubMedGoogle Scholar
  • 30 Rypens F, Dubois J, Garel L, Deslandres C, Saint-Vil D. Percutaneous drainage of abdominal abscesses in pediatric Crohn's disease. AJR Am J Roentgenol 2007; 188 (2) 579-585
    CrossrefPubMedGoogle Scholar
  • 31 Gutierrez A, Lee H, Sands BE. Outcome of surgical versus percutaneous drainage of abdominal and pelvic abscesses in Crohn's disease. Am J Gastroenterol 2006; 101 (10) 2283-2289
    CrossrefPubMedGoogle Scholar
  • 32 Lee H, Kim YH, Kim JH , et al. Nonsurgical treatment of abdominal or pelvic abscess in consecutive patients with Crohn's disease. Dig Liver Dis 2006; 38 (9) 659-664
    CrossrefPubMedGoogle Scholar
  • 33 Thoreson R, Cullen JJ. Pathophysiology of inflammatory bowel disease: an overview. Surg Clin North Am 2007; 87 (3) 575-585
    CrossrefPubMedGoogle Scholar
  • 34 Aberra FN, Lewis JD, Hass D, Rombeau JL, Osborne B, Lichtenstein GR. Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients. Gastroenterology 2003; 125 (2) 320-327
    CrossrefPubMedGoogle Scholar
  • 35 Zerbib P, Koriche D, Truant S , et al. Pre-operative management is associated with low rate of post-operative morbidity in penetrating Crohn's disease. Aliment Pharmacol Ther 2010; 32 (3) 459-465
    CrossrefPubMedGoogle Scholar
  • 36 Subramanian V, Saxena S, Kang JY, Pollok RC. Preoperative steroid use and risk of postoperative complications in patients with inflammatory bowel disease undergoing abdominal surgery. Am J Gastroenterol 2008; 103 (9) 2373-2381
    CrossrefPubMedGoogle Scholar
  • 37 Tzivanakis A, Singh JC, Guy RJ, Travis SP, Mortensen NJ, George BD. Influence of risk factors on the safety of ileocolic anastomosis in Crohn's disease surgery. Dis Colon Rectum 2012; 55 (5) 558-562
    CrossrefPubMedGoogle Scholar
  • 38 Bruewer M, Utech M, Rijcken EJ , et al. Preoperative steroid administration: effect on morbidity among patients undergoing intestinal bowel resection for Crohńs disease. World J Surg 2003; 27 (12) 1306-1310
    CrossrefPubMedGoogle Scholar
  • 39 Canedo J, Lee SH, Pinto R, Murad-Regadas S, Rosen L, Wexner SD. Surgical resection in Crohn's disease: is immunosuppressive medication associated with higher postoperative infection rates?. Colorectal Dis 2011; 13 (11) 1294-1298
    CrossrefPubMedGoogle Scholar
  • 40 Mascarenhas C, Nunoo R, Asgeirsson T , et al. Outcomes of ileocolic resection and right hemicolectomies for Crohn's patients in comparison with non-Crohn's patients and the impact of perioperative immunosuppressive therapy with biologics and steroids on inpatient complications. Am J Surg 2012; 203 (3) 375-378 , discussion 378
    CrossrefPubMedGoogle Scholar
  • 41 Schlaghecke R, Kornely E, Santen RT, Ridderskamp P. The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin-releasing hormone. N Engl J Med 1992; 326 (4) 226-230
    CrossrefPubMedGoogle Scholar
  • 42 Ackerman GL, Nolsn CM. Adrenocortical responsiveness after alternate-day corticosteroid therapy. N Engl J Med 1968; 278 (8) 405-409
    CrossrefPubMedGoogle Scholar
  • 43 Fauci AS. Alternate-day corticosteroid therapy. Am J Med 1978; 64 (5) 729-731
    CrossrefPubMedGoogle Scholar
  • 44 LaRochelle Jr GE, LaRochelle AG, Ratner RE, Borenstein DG. Recovery of the hypothalamic-pituitary-adrenal (HPA) axis in patients with rheumatic diseases receiving low-dose prednisone. Am J Med 1993; 95 (3) 258-264
    CrossrefPubMedGoogle Scholar
  • 45 Stewart PM. The adrenal cortex. In: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS, , eds. Williams Textbook of Endocrinology. 10th ed. Philadelphia, PA: Saunders; 2003: 491-551
    Google Scholar
  • 46 Livanou T, Ferriman D, James VH. Recovery of hypothalamo-pituitary-adrenal function after corticosteroid therapy. Lancet 1967; 2 (7521) 856-859
    PubMedGoogle Scholar
  • 47 Krasner AS. Glucocorticoid-induced adrenal insufficiency. JAMA 1999; 282 (7) 671-676
    CrossrefPubMedGoogle Scholar
  • 48 Myrelid P, Olaison G, Sjödahl R, Nyström PO, Almer S, Andersson P. Thiopurine therapy is associated with postoperative intra-abdominal septic complications in abdominal surgery for Crohn's disease. Dis Colon Rectum 2009; 52 (8) 1387-1394
    CrossrefPubMedGoogle Scholar
  • 49 Colombel JF, Loftus Jr EV, Tremaine WJ , et al. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy. Am J Gastroenterol 2004; 99 (5) 878-883
    CrossrefPubMedGoogle Scholar
  • 50 Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 2007; 369 (9573) 1641-1657
    CrossrefPubMedGoogle Scholar
  • 51 Hanauer SB, Feagan BG, Lichtenstein GR , et al; ACCENT I Study Group. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet 2002; 359 (9317) 1541-1549
    CrossrefPubMedGoogle Scholar
  • 52 Appau KA, Fazio VW, Shen B , et al. Use of infliximab within 3 months of ileocolonic resection is associated with adverse postoperative outcomes in Crohn's patients. J Gastrointest Surg 2008; 12 (10) 1738-1744
    CrossrefPubMedGoogle Scholar
  • 53 Marchal L, D'Haens G, Van Assche G , et al. The risk of post-operative complications associated with infliximab therapy for Crohn's disease: a controlled cohort study. Aliment Pharmacol Ther 2004; 19 (7) 749-754
    CrossrefPubMedGoogle Scholar
  • 54 Kunitake H, Hodin R, Shellito PC, Sands BE, Korzenik J, Bordeianou L. Perioperative treatment with infliximab in patients with Crohn's disease and ulcerative colitis is not associated with an increased rate of postoperative complications. J Gastrointest Surg 2008; 12 (10) 1730-1736 , discussion 1736–1737
    CrossrefPubMedGoogle Scholar
  • 55 White EC, Melmed GY, Vasiliauskas E , et al. Does preoperative immunosuppression influence unplanned hospital readmission after surgery in patients with Crohn's disease?. Dis Colon Rectum 2012; 55 (5) 563-568
    CrossrefPubMedGoogle Scholar
  • 56 Mahid SS, Minor KS, Soto RE, Hornung CA, Galandiuk S. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc 2006; 81 (11) 1462-1471
    CrossrefPubMedGoogle Scholar
  • 57 Lindberg E, Järnerot G, Huitfeldt B. Smoking in Crohn's disease: effect on localisation and clinical course. Gut 1992; 33 (6) 779-782
    CrossrefPubMedGoogle Scholar
  • 58 Galeazzi F, Blennerhassett PA, Qiu B, O'Byrne PM, Collins SM. Cigarette smoke aggravates experimental colitis in rats. Gastroenterology 1999; 117 (4) 877-883
    CrossrefPubMedGoogle Scholar
  • 59 Yamamoto T, Keighley MR. Smoking and disease recurrence after operation for Crohn's disease. Br J Surg 2000; 87 (4) 398-404
    CrossrefPubMedGoogle Scholar
  • 60 Guyatt GH, Akl EA, Crowther M, Gutterman DD, Schuünemann HJ. American College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel. Executive Summary. Chest 2012; 141 (2, Suppl): 7S-47S
    CrossrefPubMedGoogle Scholar
  • 61 Kappelman MD, Horvath-Puho E, Sandler RS , et al. Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study. Gut 2011; 60 (7) 937-943
    CrossrefPubMedGoogle Scholar
  • 62 Bernstein CN, Blanchard JF, Houston DS, Wajda A. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost 2001; 85 (3) 430-434
    PubMedGoogle Scholar
  • 63 Scarpa M, Pilon F, Pengo V , et al. Deep venous thrombosis after surgery for inflammatory bowel disease: is standard dose low molecular weight heparin prophylaxis enough?. World J Surg 2010; 34 (7) 1629-1636
    CrossrefPubMedGoogle Scholar